Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | BCHE | P06276 | 2/20 | 0.66 |
| ▸ | MAOB | P27338 | 7/20 | 0.66 |
| ▸ | APP | P05067 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.62 |
| ▸ | AR | P10275 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11846870 | 0.92 | BCHE (0.63) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL5441069 | 0.91 | MAOB (0.66) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| Acetonitrile SCHEMBL10710304 | 0.89 | MAOB (0.64) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL10991891 | 0.89 | MAOB (0.80) | LMNABCHEMAOBAPPMAOA | |
| SCHEMBL339813 | 0.89 | LMNA (0.82) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL27367676 | 0.89 | LMNA (0.82) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL11857425 | 0.88 | MAOB (0.62) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL8503299 | 0.86 | SRD5A2 (0.77) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL197713 | 0.86 | BCHE (0.53) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL3774293 | 0.85 | MRGPRX4 (0.68) | MAOBAPPMAOARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102351675-A | Preparation process of 4-chlorophenyl benzyl ketone | UNIV CHANGZHOU | 2012-02-15 | — | — | CN | claimed |
| US-20090023075-A1 | Nonaqueous electrolyte including Diphenyl ether and lithium secondary battery using thereof | PANAX ETEC CO., LTD (KR) | 2009-01-22 | — | — | US | claimed |
| EP-1979978-A1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | Cheil Industries Inc. (KR) | 2008-10-15 | — | — | EP | claimed |
| WO-2007081151-A1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | CHEIL INDUSTRIES INC. (KR) | 2007-07-19 | — | — | WO | claimed |
| WO-2005012227-A2 | PROCESS FOR PREPARATION OF 2-(3-DIISOPROPYLAMINO-1-PHENYLPROPYL)-4-HYDROXYMETHYL-PHENOL, A METABOLITE OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2005-02-10 | — | — | WO | claimed |
| US-5072017-A | Condensation of para-substituted phenol with benzylating agent in presence of faujasite type zeolite; antioxidants, bactericides | BAYER AKTIENGESELLSCHAFT (DE) | 1991-12-10 | — | — | US | claimed |
| US-11919056-B2 | Environmentally friendly excreta removal material | MODI KAPIL (IN) | 2024-03-05 | — | — | US | disclosed |
| WO-2024010810-A2 | FC CONJUGATES INCLUDING AN INHIBITOR OF CD73 AND USES THEREOF | CIDARA THERAPEUTICS, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| CN-115677480-A | TiO for preparing acid by selectively oxidizing primary alcohol under mild condition 2 Method for NaBr photocatalysis system | 东南大学 | 2023-02-03 | — | — | CN | disclosed |
| CN-112574010-B | Preparation method of triphenylene derivative | 上海康鹏科技股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20220127266-A1 | MALIC ENZYME INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2022-04-28 | — | — | US | disclosed |
| US-11225480-B2 | Malic enzyme inhibitors | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2022-01-18 | — | — | US | disclosed |
| US-20210346925-A1 | ENVIRONMENTALLY FRIENDLY EXCRETA REMOVAL MATERIAL | MODI KAPIL (IN) | 2021-11-11 | — | — | US | disclosed |
| EP-0278211-A1 | Process for the manufacture of p-substituted o-benzylphenols | BAYER AG (DE) | 1988-08-17 | — | — | EP | disclosed |
| EP-0220965-A2 | Resinous composition capable of releasing a bioactive substance at a controlled rate | Nippon Paint Co., Ltd. (JP) | 1987-05-06 | — | — | EP | disclosed |
| EP-0009787-B2 | PROCESS FOR THE MONOHALOGENATION OF ALKYLBENZENES IN ALPHA POSITION | BAYER AG (DE) | 1986-07-09 | — | — | EP | disclosed |
| US-4401821-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1983-08-30 | — | — | US | disclosed |
| EP-0044536-A1 | Plant growth regulators and their use | J.T. Baker Chemical Co. (US) | 1982-01-27 | — | — | EP | disclosed |
| EP-0009787-B1 | PROCESS FOR THE MONOHALOGENATION OF ALKYLBENZENES IN ALPHA POSITION | BAYER AG (DE) | 1982-01-13 | — | — | EP | disclosed |
| US-4267280-A | Controlled release pesticides and method of preparation | HOPKINS, MADISON WISCONSIN A CORP OF WISCONSIN | 1981-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225480-B2 | Malic enzyme inhibitors | ME1, RNASE1, ME2 | LMNA 3853/4885CYP1A2 1493/4885PTGS1 2223/4885 |
| US-20220127266-A1 | MALIC ENZYME INHIBITORS | ME1, ME2, ME3 | LMNA 4129/4885CYP1A2 2229/4885PTGS1 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.